openPR Logo
Press release

Global OTC Vitamins & Dietary Supplements Market: Future Forecast Indicates Impressive Growth Rate by Leading players- BASF SE, DuPont, Koninklijke DSM N.V., Archer Daniels Midland Company., Lonza Group Ltd, Jubilant Life Sciences Limited and more

10-25-2018 11:36 AM CET | Health & Medicine

Press release from: Fact.MR

Global OTC Vitamins & Dietary Supplements Market: Future

Over-the-counter (OTC) vitamins and dietary supplements are sold directly to consumers without any medical prescription. In many countries, OTC vitamins and dietary supplement products are regulated to ensure that they are effective and safe when used. Drug regulatory bodies allow manufacturers to formulate vitamin ingredients or combination of ingredients that are well tolerated and do not pose any risk of side effects or reactions.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=61

As per the latest report published by Fact.MR, the global OTC Vitamins and Dietary Supplements Market is poised to increase at a CAGR of 6.7% between 2017 and 2022. A positive outlook on the role of OTC vitamin and dietary supplement products in improving body endurance and muscular strength is characterizing the widespread acceptance of such products. Also, the growth of the healthcare sector and introduction of favorable government policies focused on the development of healthcare is partly responsible for the increasing popularity of various over-the-counter (OTC) drugs including vitamins and dietary supplements. A notable growth in demand for OTC vitamins and dietary supplements has been observed in emerging countries such as China, Brazil and India due to increasing awareness among consumers about the benefits of such products. In addition, factors such as self-medication in cases of minor health issues, cost-effectiveness, and convenience of direct purchase are anticipated to drive the adoption and acceptance of OTC vitamins and dietary supplements over the next couple of years. Besides, drug makers are now concentrating on innovation in the formulation of such products in order to increase their functionalities. 

North America’s Leadership in Global OTC Vitamins and Dietary Supplement Market to Remain Unchallenged

The market for OTC vitamins and dietary supplements in North America is expected to remain highly lucrative during the forecast period. Currently, the region accounts for the largest share of the global market in terms of value. This is primarily owing to soaring demand for OTC drugs particularly in the U.S. Meanwhile, the market in Asia Pacific excluding Japan (APEJ) is also expected to witness an impressive growth over the forecast period (2017-2022). By 2017-end, Europe is estimated to account for more than 31% revenue share of the global market.

By function, use of OTC vitamins and dietary supplements will be robust for the general well-being of the body. Throughout the forecast period, global revenue from sales of OTC vitamins and dietary supplements for general well-being will continue to exhibit strong growth.

Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/61/otc-vitamins-dietary-supplements-market

Pharmacies will remain the leading OCT channel for OTC vitamins and dietary supplements in 2017 and beyond. Pharmacies currently account for more than one-fourth share of the global market in terms of revenue. However, this OTC channel segment of the market is expected to lose 141 BPS toward the end of the forecast period.

Based on product form, global sales of OTC vitamin and dietary supplements capsules are expected to remain relatively higher over 2022.  Close to US$ 33 Bn worth of capsules are expected to be consumed worldwide by the end of the forecast period.

Competition Tracking

The global OTC vitamins and dietary supplements market remains highly competitive with several leading companies partaking in it, which include BASF SE, DuPont, Koninklijke DSM N.V., Archer Daniels Midland Company., Lonza Group Ltd, Jubilant Life Sciences Limited, Atrium Innovations, Inc., Sanofi S.A., Pfizer, Inc., GlaxoSmithKline plc, Dil Limited., Reckitt Benckiser LLC, CSPC Pharmaceutical Group Limited., Otsuka Holdings Co. Ltd., and Bactolac Pharmaceutical, Inc.

Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=61

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global OTC Vitamins & Dietary Supplements Market: Future Forecast Indicates Impressive Growth Rate by Leading players- BASF SE, DuPont, Koninklijke DSM N.V., Archer Daniels Midland Company., Lonza Group Ltd, Jubilant Life Sciences Limited and more here

News-ID: 1328185 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to